Qdrant was engineered from the ground up for performance, scale, and flexibility — and Oncotelic Therapeutics put it to the test. Indexing 28M PubMed abstracts to power AI-driven drug development, Oncotelic compressed concept-to-clinic to ~2 years — a fraction of the typical biotech timeline. In this conversation, Qdrant Engineering and Oncotelic walk through what matters most for search at scale: hybrid retrieval, MeSH-enriched metadata filtering, and the operational realities of running a vector database in production. Learn more >

Dr. Vuong Trieu, Chairman & CEO of Oncotelic, presented at the 5th Symposium on World Cancer Research (SWCR 2025). Kyoto, Japan (May 24-26, 2025) Learn more >

Dr. Vuong Trieu presented at the BIO International Convention 2023, Boston, MA (June 5-8, 2023) Learn more >

Dr. Vuong Trieu presented at the 12th AACR-JCA Joint Conference: Breakthroughs in Cancer Research— Translating Knowledge into Practice (December 10 – 14, 2022, Maui, Hawaii) Learn more >

Dr. Cynthia Lee etc. presented at the SNO 2022 conference (November 16-20, 2022 | Tampa bay, FL)

Learn more 1>

Learn more 2>

Dr. Anthony Maida presented at the SITC 2022 conference (November 8-12, 2022 | Boston, MA) Learn more >

Dr. Vuong Trieu presented at the 7th JCA-AACR Special Joint Conference (July 8-10, 2022) Learn more >

Dr. Vuong Trieu presented at the BIO International Convention, San Diego (June 13-16, 2022) Learn more >

Biotechgate Digital Partnering February 2022 (7 – 11 Feb, 2022) Learn more >

2^nd Annual TGF-β for Immuno-Oncology Drug Development Summit (tgf-beta-summit.com) (January 25, 2022 to January 27, 2022) Learn more >